- The Impact of Long-Term Antibiotic Therapy of Cutaneous Adverse Reactions to EGFR Inhibitors in Colorectal Cancer Patients2021 | Faculty of Medicine in Pilsen
- Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis2019 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Cutaneous side-effects resembling ac*ne in the treatment with targeted drugs in oncology2010 | Faculty of Medicine in Pilsen
- Monitoring of KRAS mutation during cetuximab treatment of head and neck squamous cell carcinoma2012 | First Faculty of Medicine
- Synthesis, characterization and biological evaluation of In(III) complexes anchored by DOTA-like chelators bearing a quinazoline moiety2010 | Faculty of Science
- Combination of neoadjuvant chemoradiotherapy and epidermal growth factor receptor inhibitors in the treatment of rectal adenocarcinoma2014 | First Faculty of Medicine
- Treatment of non-small cell lung cancer with a driver mutation2022 | Faculty of Medicine in Pilsen
- Possibilities and substantiation of re-treatment with anti-EGFR drugs for pre-treated RAS wild-type advanced colorectal cancers2021 | Publication without faculty affiliation
- Alopecia and hair damage induced by oncological therapy2019 | Faculty of Medicine in Pilsen
- Two perspectives on venous thromboembolism in oncology2017 | Faculty of Medicine in Pilsen
- Next-Generation Sequencing of Circulating Tumor DNA Can Optimize Second-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer after Progression on anti-EGFR Therapy: Time to Rethink Our Approach2022 | Publication without faculty affiliation